Insider Trading History of Clancy Paul J

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Clancy Paul J since 2008. This trader's CIK number is 1409601. At the time of last reporting, Clancy Paul J was the Officer of Agios Pharmaceuticals, Inc.. (stock ticker symbol AGIO). Also see all insider trading activities at Agios Pharmaceuticals, Inc..

Note that in the past Clancy Paul J also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Agios Pharmaceuticals, Inc. (AGIO) by Clancy Paul J

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 AGIO 0 $0 0 $0 1,585 $0
2021 AGIO 0 $0 0 $0 1,686 $0
2020 AGIO 0 $0 0 $0 1,878 $0
2019 AGIO 0 $0 0 $0 1,400 $0

Yearly summary of insider trading at Biogen Inc. (BIIB) by Clancy Paul J

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2017 BIIB 0 $0 19,783 $5,752,401 6,780 $0
2016 BIIB 0 $0 0 $0 3,859 $0
2015 BIIB 0 $0 0 $0 12,181 $0
2014 BIIB 0 $0 0 $0 14,969 $0
2013 BIIB 0 $0 149,427 $35,436,546 137,553 $6,453,489
2012 BIIB 0 $0 41,644 $4,844,559 30,373 $1,188,449
2011 BIIB 0 $0 19,716 $1,954,033 47,037 $2,334,443
2008 BIIB 0 $0 9,470 $532,153 0 $0

Yearly summary of insider trading at Alexion Pharmaceuticals, Inc. (ALXN) by Clancy Paul J

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2018 ALXN 0 $0 11,320 $1,394,195 0 $0


Insider trading activities at 3 companies by Clancy Paul J:

1. Agios Pharmaceuticals, Inc. (AGIO)

2. Biogen Inc. (BIIB)

3. Alexion Pharmaceuticals, Inc. (ALXN)

Table 1. Insider trading of Agios Pharmaceuticals, Inc. (AGIO) by Clancy Paul J

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-05-20 AGIO Option Ex 1,585 .00 0
2021-05-28 AGIO Option Ex 1,686 .00 0
2020-05-29 AGIO Option Ex 1,878 .00 0
2019-05-31 AGIO Option Ex 1,400 .00 0

Table 2. Insider trading of Biogen Inc. (BIIB) by Clancy Paul J

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2017-04-25 BIIB Sale 9,892 290.00 2,868,680
2017-03-13 BIIB Sale 9,891 291.55 2,883,721
2017-02-28 BIIB Option Ex 6,780 .00 0
2016-02-12 BIIB Option Ex 3,859 .00 0
2015-02-12 BIIB Option Ex 4,299 .00 0
2015-02-08 BIIB Option Ex 3,191 .00 0
2015-02-09 BIIB Option Ex 4,691 .00 0
2014-02-23 BIIB Option Ex 4,280 .00 0
2014-02-12 BIIB Option Ex 2,807 .00 0
2014-02-08 BIIB Option Ex 3,191 .00 0
2014-02-09 BIIB Option Ex 4,691 .00 0
2013-09-18 BIIB Option Ex 26,785 49.65 1,329,875
2013-09-18 BIIB Sale 26,785 245.00 6,562,325
2013-09-16 BIIB Option Ex 99,030 51.74 5,123,614
2013-09-16 BIIB Sale 99,030 238.47 23,615,882
2013-04-29 BIIB Sale 9,123 219.71 2,004,414
2013-04-30 BIIB Sale 14,489 224.58 3,253,925
2013-02-23 BIIB Option Ex 4,281 .00 0
2013-02-09 BIIB Option Ex 4,692 .00 0
2013-02-08 BIIB Option Ex 2,765 .00 0
2012-02-23 BIIB Option Ex 4,281 .00 0
2012-02-09 BIIB Option Ex 4,692 .00 0
2012-02-01 BIIB Option Ex 21,400 55.53 1,188,449
2012-02-01 BIIB Sale 21,400 120.00 2,568,000
2012-01-03 BIIB Sale 20,244 112.46 2,276,559
2011-04-28 BIIB Option Ex 14,766 43.24 638,481
2011-04-28 BIIB Sale 19,716 99.11 1,954,033
2011-03-05 BIIB Option Ex 28,750 58.99 1,695,962
2011-02-23 BIIB Option Ex 3,521 .00 0
2008-09-19 BIIB Sale 1,553 50.00 77,650
2008-08-08 BIIB Sale 568 50.66 28,777
2008-07-01 BIIB Sale 4,208 56.01 235,677
2008-02-21 BIIB Sale 2,183 60.29 131,621
2008-02-12 BIIB Sale 958 60.99 58,428

Table 3. Insider trading of Alexion Pharmaceuticals, Inc. (ALXN) by Clancy Paul J

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2018-07-10 ALXN Sale 5,241 131.11 687,147
2018-02-08 ALXN Sale 6,079 116.31 707,048

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Clancy Paul J (Officer of Agios Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.